The HLA-DRB1*15:01 allele had the most significant effect, exhibiting a notably elevated gene frequency compared to the control group, thereby elevating the risk of developing MS by approximately threefold (Beecham et al. 2013; Hafler et al. 2007). Here, HLA-DRB1 is linked to myeloid sarcoma.